Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
| Autor Principal: | Rahman, Tasnim |
|---|---|
| Outros autores: | Azam, Faruque |
| Formato: | Thesis |
| Idioma: | English |
| Publicado: |
Brac University
2024
|
| Subjects: | |
| Acceso en liña: | http://hdl.handle.net/10361/22174 |
Títulos similares
-
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
por: Paul, Pulock
Publicado: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
por: Flora, Sanzida Alam
Publicado: (2024) -
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
por: Hoque, Ismoth Ara
Publicado: (2024) -
A review on targeted therapies for lung cancer
por: Ashraf, Anushey
Publicado: (2023) -
Potential of liposomes for the treatment of lung cancer- a review
por: Mim, Shanzida
Publicado: (2023)